{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:31:43Z","timestamp":1777984303858,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The SJTU Research Physician Fund"},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China Fund","doi-asserted-by":"crossref","award":["82470706, 82470761, 82500817"],"award-info":[{"award-number":["82470706, 82470761, 82500817"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Shanghai Scientific and Technological Committee Fund","award":["24YF2727300, 25ZR1402064"],"award-info":[{"award-number":["24YF2727300, 25ZR1402064"]}]},{"name":"The Construction Project of the \u201cDiscipline Peak Climbing Plan\u201d of Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine","award":["XKPF2024B301"],"award-info":[{"award-number":["XKPF2024B301"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04775-7","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T11:23:35Z","timestamp":1769685815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deciphering the complexity: a case of kidney failure with co-inheritance of COL4A5 and APOE variants"],"prefix":"10.1186","volume":"27","author":[{"given":"Xiaoyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuantong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenlin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fujun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"issue":"4","key":"4775_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/ndt\/gfab019","volume":"37","author":"A Domingo-Gallego","year":"2022","unstructured":"Domingo-Gallego A, et al. Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players. Nephrol Dial Transpl. 2022;37(4):687\u201396.","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"4775_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1806891","volume":"380","author":"EE Groopman","year":"2019","unstructured":"Groopman EE, et al. Diagnostic utility of exome sequencing for kidney disease. N Engl J Med. 2019;380(2):142\u201351.","journal-title":"N Engl J Med"},{"issue":"12","key":"4775_CR3","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1681\/ASN.0000000000000249","volume":"34","author":"NK Dahl","year":"2023","unstructured":"Dahl NK, et al. The clinical utility of genetic testing in the diagnosis and management of adults with chronic kidney disease. J Am Soc Nephrol. 2023;34(12):2039\u201350.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"4775_CR4","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ekir.2022.12.007","volume":"8","author":"A Doreille","year":"2023","unstructured":"Doreille A, et al. Exome-First strategy in adult patients with CKD: A cohort study. Kidney Int Rep. 2023;8(3):596\u2013605.","journal-title":"Kidney Int Rep"},{"issue":"5","key":"4775_CR5","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/cge.13606","volume":"96","author":"J Rao","year":"2019","unstructured":"Rao J, et al. Genetic spectrum of renal disease for 1001 Chinese children based on a multicenter registration system. Clin Genet. 2019;96(5):402\u201310.","journal-title":"Clin Genet"},{"issue":"6","key":"4775_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1053\/j.ajkd.2021.04.017","volume":"78","author":"J Savige","year":"2021","unstructured":"Savige J, et al. Pathogenic variants in the genes affected in Alport syndrome (COL4A3-COL4A5) and their association with other kidney conditions: A review. Am J Kidney Dis. 2021;78(6):857\u201364.","journal-title":"Am J Kidney Dis"},{"key":"4775_CR7","doi-asserted-by":"crossref","unstructured":"Deltas C et al. Genetic modifiers of Mendelian Monogenic collagen IV nephropathies in humans and mice. Genes (Basel). 2023; 4(9).","DOI":"10.3390\/genes14091686"},{"issue":"5","key":"4775_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"2","key":"4775_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1046\/j.1523-1755.1999.00572.x","volume":"56","author":"A Matsunaga","year":"1999","unstructured":"Matsunaga A, et al. A novel Apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy. Kidney Int. 1999;56(2):421\u20137.","journal-title":"Kidney Int"},{"issue":"2","key":"4775_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.kint.2019.10.031","volume":"97","author":"T Saito","year":"2020","unstructured":"Saito T, et al. Apolipoprotein E-related glomerular disorders. Kidney Int. 2020;97(2):279\u201388.","journal-title":"Kidney Int"},{"issue":"12","key":"4775_CR11","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/nep.14399","volume":"29","author":"L Yang","year":"2024","unstructured":"Yang L, et al. First patient diagnosed with lipoprotein glomerulopathy and Alport syndrome. Nephrol (Carlton). 2024;29(12):985\u20139.","journal-title":"Nephrol (Carlton)"},{"issue":"6","key":"4775_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1053\/j.ajkd.2024.05.010","volume":"84","author":"N Franceschini","year":"2024","unstructured":"Franceschini N, et al. Advancing genetic testing in kidney diseases: report from a National kidney foundation working group. Am J Kidney Dis. 2024;84(6):751\u201366.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4775_CR13","doi-asserted-by":"publisher","first-page":"sfad099","DOI":"10.1093\/ckj\/sfad099","volume":"17","author":"T Robert","year":"2024","unstructured":"Robert T, et al. Beyond the kidney biopsy: genomic approach to undetermined kidney diseases. Clin Kidney J. 2024;17(1):sfad099.","journal-title":"Clin Kidney J"},{"issue":"4","key":"4775_CR14","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1053\/j.ajkd.2019.12.008","volume":"76","author":"KM Riedhammer","year":"2020","unstructured":"Riedhammer KM, et al. Exome sequencing and identification of phenocopies in patients with clinically presumed hereditary nephropathies. Am J Kidney Dis. 2020;76(4):460\u201370.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"4775_CR15","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/ki.2013.335","volume":"85","author":"Z Hu","year":"2014","unstructured":"Hu Z, et al. Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation. Kidney Int. 2014;85(2):416\u201324.","journal-title":"Kidney Int"},{"issue":"6","key":"4775_CR16","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/ndt\/gfae265","volume":"40","author":"R Torra","year":"2025","unstructured":"Torra R, et al. Diagnosis, management and treatment of the Alport syndrome \u2013\u20092024 guideline on behalf of ERKNet, ERA and ESPN. Nephrol Dial Transpl. 2025;40(6):1091\u2013106.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"4775_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13000-025-01636-z","volume":"20","author":"X Yi","year":"2025","unstructured":"Yi X, et al. Normolipidemic lipoprotein glomerulopathy with IgA nephropathy - ApoE Kyoto mutation: a case report. Diagn Pathol. 2025;20(1):36.","journal-title":"Diagn Pathol"},{"issue":"3","key":"4775_CR18","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s40620-022-01491-x","volume":"36","author":"H Liu","year":"2023","unstructured":"Liu H, et al. The first case of lipoprotein glomerulopathy complicated with collagen type III glomerulopathy and literature review. J Nephrol. 2023;36(3):663\u20137.","journal-title":"J Nephrol"},{"issue":"1","key":"4775_CR19","doi-asserted-by":"publisher","first-page":"2332491","DOI":"10.1080\/0886022X.2024.2332491","volume":"46","author":"Y Qin","year":"2024","unstructured":"Qin Y, et al. Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy. Ren Fail. 2024;46(1):2332491.","journal-title":"Ren Fail"},{"key":"4775_CR20","doi-asserted-by":"publisher","first-page":"905007","DOI":"10.3389\/fmed.2022.905007","volume":"9","author":"MS Li","year":"2022","unstructured":"Li MS, et al. An updated review and meta analysis of lipoprotein glomerulopathy. Front Med (Lausanne). 2022;9:905007.","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"4775_CR21","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1681\/ASN.0000000000000186","volume":"34","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, et al. Finerenone added to RAS\/SGLT2 Blockade for CKD in Alport Syndrome. Results of a randomized controlled trial with Col4a3-\/- mice. J Am Soc Nephrol. 2023;34(9):1513\u201320.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"4775_CR22","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.ekir.2023.12.014","volume":"9","author":"ZR Song","year":"2024","unstructured":"Song ZR, et al. Protective effects of selective mineralocorticoid receptor antagonist in Alport syndrome on top of Renin-Angiotensin-System\/ Sodium-Glucose transporter 2 Blockade. Kidney Int Rep. 2024;9(3):730\u20131.","journal-title":"Kidney Int Rep"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04775-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04775-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04775-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:17:26Z","timestamp":1771597046000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04775-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4775"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04775-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7858921\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board (or Ethics Committee) of Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine (XHEC-C-2024-185-2).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The present work was conducted in accordance with the Declaration of Helsinki and informed consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent for publication of their clinical details was obtained from the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}